Workflow
Fire Safety
icon
Search documents
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT
Globenewswire· 2025-07-07 10:00
Core Viewpoint - Cyclacel Pharmaceuticals has amended its Exchange Agreement with FITTERS Diversified Berhad to facilitate the acquisition of Fitters Sdn. Bhd., a subsidiary of FITTERS, through the exchange of shares and a cash payment [1][2][3]. Company Overview - Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative cancer medicines based on cell cycle, epigenetics, and mitosis biology [6]. - The company is evaluating plogosertib, a PLK1 inhibitor, in patients with solid tumors and hematological malignancies, aiming to build a diversified biopharmaceutical business [6]. Transaction Details - Under the amended Exchange Agreement, Cyclacel will exchange all ordinary shares of Fitters Sdn. Bhd. for common stock, representing 19.99% of Cyclacel's issued and outstanding shares at closing [2]. - Cyclacel will also pay USD 1,000,000 or a mutually agreed amount to FITTERS as part of the transaction [2]. - The final date for the transaction has been extended to September 30, 2025 [2]. Approval and Governance - The transaction is subject to approval from the stockholders of both Cyclacel and FITTERS, and has been unanimously approved by the Boards of Directors of Cyclacel, FITTERS, and Fitters Sub [3]. Fitters Sdn. Bhd. Overview - Fitters Sdn. Bhd. specializes in distributing, trading, and installing fire safety materials and equipment, with a strong reputation for reliability and compliance with regulatory standards [4][8]. - The company offers a wide range of fire safety products, including fire extinguishers, fire-resistant doors, and personal protective equipment [8].
Perimeter Solutions Reports First Quarter 2025 Financial Results
Newsfile· 2025-05-08 10:00
Perimeter Solutions Reports First Quarter 2025 Financial ResultsMay 08, 2025 6:00 AM EDT | Source: Perimeter SolutionsFirst quarter Net Income of $56.7M and Adjusted Net Income of $4.1MStrong execution and early season fire activity drove first quarter Adjusted EBITDA of $18.1MFirst quarter Earnings Per Diluted Share of $0.36 and Adjusted Earnings Per Diluted Share of $0.03First IMS add-on product line acquisitions completedClayton, Missouri--(Newsfile Corp. - May 8, 2025) - Perimeter Solution ...
Fire safety: Chubb France deploys AMA's assisted reality for remote troubleshooting
Globenewswire· 2025-05-05 08:30
Fire safety: Chubb France deploys AMA's assisted realityfor remote troubleshooting Cergy, Rennes, May 5, 2025 - To speed up the resolution of technical faults, Chubb France, a major player in the fire safety sector, is integrating AMA’s assisted reality into its operations. The aim is to increase efficiency and reduce the number of journeys required to guarantee fast, safe assistance. XpertEye software for remote troubleshooting The partnership has resulted to complement Chubb's tools in the introduction o ...
Perimeter Announces Date for First Quarter 2025 Earnings Call
Newsfile· 2025-04-30 21:00
Core Points - Perimeter Solutions will release its financial results for Q1 2025 on May 8, 2025, before market opens [1] - A conference call to discuss these results will be held on the same day at 8:30 AM ET, led by CEO Haitham Khouri, CFO Kyle Sable, and Head of Investor Relations Seth Barker [2] Company Overview - Perimeter Solutions is a leading global provider in the Fire Safety and Specialty Products industries, headquartered in St. Louis, Missouri [3] - The company operates in two segments: Fire Safety, which includes fire retardants and firefighting foams, and Specialty Products, which focuses on non-fire safety markets, including phosphorus pentasulfide-based lubricant additives [3] - The Specialty Products segment also encompasses IMS, a manufacturer of electronic components for various end markets, emphasizing aftermarket repair and replacement [3]
IDEX(IEX) - 2024 Q4 - Earnings Call Transcript
2025-02-05 16:30
IDEX (IEX) Q4 2024 Earnings Call February 05, 2025 10:30 AM ET Company Participants Wendy Palacios - Vice President of FP&A and Investor RelationsEric Ashleman - Chief Executive Officer and PresidentAbhishek Khandelwal - Senior VP & CFOMichael Halloran - Associate Director of ResearchNathan Jones - Managing DirectorDeane Dray - Managing DirectorJoseph Giordano - Managing DirectorBrett Linzey - Executive DirectorAndrew Buscaglia - Executive DirectorRob Wertheimer - Director of Research Conference Call Partic ...